News
CMMB
1.740
0.00%
0.000
Chemomab Therapeutics GAAP EPS of -$0.01 beats by $0.05
Seeking Alpha · 12h ago
Chemomab’s Positive Trial Results Boost Investor Confidence
TipRanks · 15h ago
Chemomab Therapeutics sees cash runway through beginning of 2026
TipRanks · 15h ago
Chemomab Therapeutics Q3 2024 GAAP EPS $(0.20) Misses $(0.01) Estimate
Benzinga · 15h ago
CHEMOMAB THERAPEUTICS LTD : QTRLY SHR LOSS $0.01
Reuters · 15h ago
Earnings Scheduled For November 14, 2024
Benzinga · 19h ago
Weekly Report: what happened at CMMB last week (1104-1108)?
Weekly Report · 3d ago
Weekly Report: what happened at CMMB last week (1028-1101)?
Weekly Report · 11/04 11:30
Weekly Report: what happened at CMMB last week (1021-1025)?
Weekly Report · 10/28 11:22
Weekly Report: what happened at CMMB last week (1014-1018)?
Weekly Report · 10/21 11:18
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 10/18 13:30
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/15 12:08
CHEMOMAB THERAPEUTICS ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF CM-101 PHASE 2 RESULTS IN PRIMARY SCLEROSING CHOLANGITIS AT AASLD THE LIVER MEETING® 2024
Reuters · 10/15 11:00
Weekly Report: what happened at CMMB last week (1007-1011)?
Weekly Report · 10/14 11:48
Chemomab Therapeutics Announces Shareholder Meeting
TipRanks · 10/11 20:28
Weekly Report: what happened at CMMB last week (0930-1004)?
Weekly Report · 10/07 11:37
Weekly Report: what happened at CMMB last week (0923-0927)?
Weekly Report · 09/30 11:30
Weekly Report: what happened at CMMB last week (0916-0920)?
Weekly Report · 09/23 11:29
BRIEF-Carl Gordon Reports 9.99% Stake In Chemomab Therapeutics As Of Sept 12 Versus 16.0% As Reported In March 11 - SEC Filing
Reuters · 09/16 22:43
Weekly Report: what happened at CMMB last week (0909-0913)?
Weekly Report · 09/16 11:18
More
Webull provides a variety of real-time CMMB stock news. You can receive the latest news about Chemomab Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CMMB
Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.